C4 Therapeutics (NASDAQ:CCCC) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
C4 Therapeutics missed estimated earnings by 12.07%, reporting an EPS of $-0.65 versus an estimate of $-0.58.
Revenue was up $228.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.27 which was followed by a 0.09% drop in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for C4 Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
